Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure.

Chen YB, Elias N, Heher E, McCune JS, Collier K, Li S, Del Rio C, El-Jawahri A, Williams W, Tolkoff-Rubin N, Fishman JA, McAfee S, Dey BR, DeFilipp Z, O'Donnell PV, Cosimi AB, Sachs D, Kawai T, Spitzer TR.

Blood. 2019 Jul 11;134(2):211-215. doi: 10.1182/blood.2019000775. Epub 2019 May 31.

PMID:
31151984
2.

When acute kidney injury in the intensive care unit is not acute tubular necrosis: A case report of κ-light chain crystalline tubulopathy
.

Shah N, Rosales I, Smith RN, Berchuck JE, Yee AJ, Tolkoff-Rubin N.

Clin Nephrol. 2019 May;91(5):311-316. doi: 10.5414/CN109693.

PMID:
30935459
3.

Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.

Spitzer TR, Tolkoff-Rubin N, Cosimi AB, McAfee S, Dey BR, Chen YB, Delmonico F, Sykes M, Sachs DH, Kawai T.

Transplantation. 2019 Nov;103(11):2366-2372. doi: 10.1097/TP.0000000000002669.

PMID:
30801529
4.

Hemodialysis failure secondary to hydroxocobalamin exposure.

Lim K, Heher E, Steele D, Fenves AZ, Tucker JK, Thadhani R, Christopher K, Tolkoff-Rubin N.

Proc (Bayl Univ Med Cent). 2017 Apr;30(2):167-168.

5.

Lanthanum deposition from oral lanthanum carbonate in the upper gastrointestinal tract.

Hoda RS, Sanyal S, Abraham JL, Everett JM, Hundemer GL, Yee E, Lauwers GY, Tolkoff-Rubin N, Misdraji J.

Histopathology. 2017 Jun;70(7):1072-1078. doi: 10.1111/his.13178. Epub 2017 Mar 21.

6.

Voriconazole-Induced Periostitis & Enthesopathy in Solid Organ Transplant Patients: Case Reports.

Sircar M, Kotton C, Wojciechowski D, Safa K, Gilligan H, Heher E, Williams W, Thadhani R, Tolkoff-Rubin N.

J Biosci Med (Irvine). 2016 Nov;4(11):8-17. Epub 2016 Nov 10.

7.

Hydroxyurea for Treatment of Nephrotic Syndrome Associated With Polycythemia Vera.

Hundemer GL, Rosales IA, Chen YB, Colvin RB, Tolkoff-Rubin NE.

Am J Kidney Dis. 2016 Sep;68(3):465-8. doi: 10.1053/j.ajkd.2016.02.056. Epub 2016 Apr 29.

PMID:
27133437
8.

Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.

Newell KA, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, Kanaparthi S, Asare S, Lim N, Stahly M, Howell M, Knechtle S, Kirk A, Marks WH, Kawai T, Spitzer T, Tolkoff-Rubin N, Sykes M, Sachs DH, Cosimi AB, Burlingham WJ, Phippard D, Turka LA.

Am J Transplant. 2015 Nov;15(11):2908-20. doi: 10.1111/ajt.13480. Epub 2015 Oct 13.

9.

Immune Complex Tubulointerstitial Nephritis Due to Autoantibodies to the Proximal Tubule Brush Border.

Rosales IA, Collins AB, do Carmo PA, Tolkoff-Rubin N, Smith RN, Colvin RB.

J Am Soc Nephrol. 2016 Feb;27(2):380-4. doi: 10.1681/ASN.2015030334. Epub 2015 Sep 2.

10.

BK Virus After Kidney Transplantation: A Review of Screening and Treatment Strategies and a Summary of the Massachusetts General Hospital Experience.

Safa K, Heher E, Gilligan H, Williams W Jr, Tolkoff-Rubin N, Wojciechowski D.

Clin Transpl. 2015;31:257-263.

PMID:
28514587
11.

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, Hayden D, Shui A, Brooks B, Conwit R, Felsenstein D, Greenblatt DJ, Keroack M, Kissel JT, Miller R, Rosenfeld J, Rothstein JD, Simpson E, Tolkoff-Rubin N, Zinman L, Shefner JM; Ceftriaxone Study Investigators.

Lancet Neurol. 2014 Nov;13(11):1083-1091. doi: 10.1016/S1474-4422(14)70222-4. Epub 2014 Oct 5.

12.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB.

Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.

13.

Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation.

Elias N, Kawai T, Ko DS, Saidi R, Tolkoff-Rubin N, Wicky S, Cosimi AB, Hertl M.

Am J Transplant. 2013 Oct;13(10):2739-42. doi: 10.1111/ajt.12381. Epub 2013 Aug 5.

14.

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Smith RN, Malik F, Goes N, Farris AB, Zorn E, Saidman S, Tolkoff-Rubin N, Puri S, Wong W.

Transpl Immunol. 2012 Oct;27(2-3):107-13. doi: 10.1016/j.trim.2012.08.005. Epub 2012 Aug 30.

15.

Clinical role of the renal transplant biopsy.

Williams WW, Taheri D, Tolkoff-Rubin N, Colvin RB.

Nat Rev Nephrol. 2012 Jan 10;8(2):110-21. doi: 10.1038/nrneph.2011.213. Review.

16.

Early outcomes among those initiating chronic dialysis in the United States.

Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2642-9. doi: 10.2215/CJN.03680411. Epub 2011 Sep 29.

17.

Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person.

Fickie MR, Lapunzina P, Gentile JK, Tolkoff-Rubin N, Kroshinsky D, Galan E, Gean E, Martorell L, Romanelli V, Toral JF, Lin AE.

Am J Med Genet A. 2011 Sep;155A(9):2105-11. doi: 10.1002/ajmg.a.34156. Epub 2011 Aug 10. Review.

PMID:
21834047
18.

Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.

Baid-Agrawal S, Farris AB 3rd, Pascual M, Mauiyyedi S, Farrell ML, Tolkoff-Rubin N, Collins AB, Frei U, Colvin RB.

Kidney Int. 2011 Oct;80(8):879-85. doi: 10.1038/ki.2011.194. Epub 2011 Jun 22.

19.

Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.

Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffer FI, Locascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB.

Am J Transplant. 2011 Jul;11(7):1464-77. doi: 10.1111/j.1600-6143.2011.03572.x. Epub 2011 Jun 10.

20.

Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation.

Andreola G, Chittenden M, Shaffer J, Cosimi AB, Kawai T, Cotter P, Locascio SA, Morokata T, Dey BR, Tolkoff-Rubin NT, Preffer F, Bonnefoix T, Kattleman K, Spitzer TR, Sachs DH, Sykes M.

Am J Transplant. 2011 Jun;11(6):1236-47. doi: 10.1111/j.1600-6143.2011.03566.x.

21.

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.

Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, Ballen K, Delmonico F, Saidman S, Sachs DH, Cosimi AB.

Transplantation. 2011 Mar 27;91(6):672-6. doi: 10.1097/TP.0b013e31820a3068.

22.

Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.

LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman SL, Spitzer TR, Tolkoff-Rubin N, Cosimi AB, Sachs DH, Sykes M.

Transplantation. 2010 Dec 27;90(12):1607-15. doi: 10.1097/TP.0b013e3181ffbaff.

23.

Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine.

Wong W, DeVito J, Nguyen H, Sarracino D, Porcheray F, Dargon I, Pelle PD, Collins AB, Tolkoff-Rubin N, Smith RN, Colvin R, Zorn E.

Am J Transplant. 2010 Nov;10(11):2463-71. doi: 10.1111/j.1600-6143.2010.03290.x.

24.

Accurate, fast, and convenient measurement of glomerular filtration rate in potential renal transplant donors.

Rabito C, Halpern EF, Scott J, Tolkoff-Rubin N.

Transplantation. 2010 Sep 15;90(5):510-7. doi: 10.1097/TP.0b013e3181e9139d.

PMID:
20595931
25.

B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Porcheray F, Wong W, Saidman SL, De Vito J, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E.

Am J Transplant. 2009 Sep;9(9):2126-35. doi: 10.1111/j.1600-6143.2009.02738.x. Epub 2009 Jul 16.

26.

Deceased donor kidney transplantation in elderly patients: is there a difference in outcomes?

Saidi RF, Kennealey PT, Elias N, Kawai T, Hertl M, Farrell M, Goes N, Hartono C, Tolkoff-Rubin N, Cosimi AB, Ko DS.

Transplant Proc. 2008 Dec;40(10):3413-7. doi: 10.1016/j.transproceed.2008.08.127.

PMID:
19100401
27.

My most interesting cases.

Kawai T, Sachs DH, Sykes M, Spitzer T, Tolkoff-Rubin N, Saidman S, Ko D, Dey B, Colvin RB, Cosimi AB.

Clin Transpl. 2006:580-2. No abstract available.

PMID:
18365443
28.

HLA-mismatched renal transplantation without maintenance immunosuppression.

Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH.

N Engl J Med. 2008 Jan 24;358(4):353-61. doi: 10.1056/NEJMoa071074.

29.

Hepatitis C virus infection in haemodialysis and kidney transplant patients.

Baid-Agrawal S, Pascual M, Moradpour D, Frei U, Tolkoff-Rubin N.

Rev Med Virol. 2008 Mar-Apr;18(2):97-115. Review.

PMID:
18064722
30.

Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs.

Saidi RF, Elias N, Kawai T, Hertl M, Farrell ML, Goes N, Wong W, Hartono C, Fishman JA, Kotton CN, Tolkoff-Rubin N, Delmonico FL, Cosimi AB, Ko DS.

Am J Transplant. 2007 Dec;7(12):2769-74. Epub 2007 Oct 10.

31.

Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.

Collins AB, Chicano SL, Cornell LD, Tolkoff-Rubin N, Goes NB, Saidman SL, Farrell ML, Cosimi AB, Colvin RB.

Transplant Proc. 2006 Dec;38(10):3427-9.

PMID:
17175293
32.

Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys.

McDougal WS, Tolkoff-Rubin NE, Michaelson MD, Mueller PR, Braaten K.

N Engl J Med. 2006 Sep 14;355(11):1161-7. No abstract available.

PMID:
16971723
33.

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.

Wong W, Agrawal N, Pascual M, Anderson DC, Hirsch HH, Fujimoto K, Cardarelli F, Winkelmayer WC, Cosimi AB, Tolkoff-Rubin N.

Transpl Int. 2006 Aug;19(8):629-35.

34.

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman SL, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M.

Am J Transplant. 2006 Sep;6(9):2121-33. Epub 2006 Jun 22.

35.

Reproduction and pregnancy in transplant recipients: current practices.

McKay DB, Adams PL, Bumgardner GL, Davis CL, Fine RN, Krams SM, Martinez OM, Murphy B, Pavlakis M, Tolkoff-Rubin N, Sherman MS, Josephson MA.

Prog Transplant. 2006 Jun;16(2):127-32.

PMID:
16789701
36.

2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?

Wong W, Venetz JP, Tolkoff-Rubin N, Pascual M.

Transplantation. 2005 Aug 15;80(3):289-96. Review.

PMID:
16082321
37.

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.

McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, Davison JM, Easterling T, Friedman JE, Hou S, Karlix J, Lake KD, Lindheimer M, Matas AJ, Moritz MJ, Riely CA, Ross LF, Scott JR, Wagoner LE, Wrenshall L, Adams PL, Bumgardner GL, Fine RN, Goral S, Krams SM, Martinez OM, Tolkoff-Rubin N, Pavlakis M, Scantlebury V; Women's Health Committee of the American Society of Transplantation.

Am J Transplant. 2005 Jul;5(7):1592-9. Review.

38.

Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.

Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.

Transpl Int. 2005 May;18(5):532-40.

39.

Hepatitis C, acute humoral rejection, and renal allograft survival.

Forman JP, Tolkoff-Rubin N, Pascual M, Lin J.

J Am Soc Nephrol. 2004 Dec;15(12):3249-55.

40.

Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation.

Forman JP, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N.

Am J Transplant. 2004 Nov;4(11):1786-91.

41.

Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies.

Cardarelli F, Pascual M, Chung RT, Tolkoff-Rubin N, Wong W, Cosimi AB, Saidman SL.

Am J Transplant. 2004 Aug;4(8):1352-6.

42.

Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.

Wong W, Tolkoff-Rubin N, Delmonico FL, Cardarelli F, Saidman SL, Farrell ML, Shih V, Winkelmayer WC, Cosimi AB, Pascual M.

Clin Transplant. 2004 Aug;18(4):341-8.

PMID:
15233807
43.

Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.

Baid-Agrawal S, Delmonico FL, Tolkoff-Rubin NE, Farrell M, Williams WW, Shih V, Auchincloss H, Cosimi AB, Pascual M.

Transplantation. 2004 Apr 27;77(8):1199-202.

PMID:
15114085
44.

Reproductive and contraceptive characteristics of premenopausal kidney transplant recipients.

Mattix Kramer HJ, Tolkoff-Rubin NE, Williams WW, Cosimi AB, Pascual MA.

Prog Transplant. 2003 Sep;13(3):193-6.

PMID:
14558633
45.

A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.

Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB.

Transplantation. 2003 Sep 15;76(5):798-802.

PMID:
14501856
46.

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation.

Pascual M, Curtis J, Delmonico FL, Farrell ML, Williams WW Jr, Kalil R, Jones P, Cosimi AB, Tolkoff-Rubin N.

Transplantation. 2003 May 15;75(9):1501-5.

PMID:
12792504
47.

The problem of late allograft loss in kidney transplantation.

Cardarelli F, Saidman S, Theruvath T, Tolkoff-Rubin N, Cosimi AB, Pascual M.

Minerva Urol Nefrol. 2003 Mar;55(1):1-11. Review.

PMID:
12773962
48.

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, Auchincloss H, Colvin RB, Delmonico FL, Cosimi AB, Pascual M.

Am J Transplant. 2003 Jan;3(1):74-8.

49.

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

Bühler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB.

Transplantation. 2002 Nov 27;74(10):1405-9.

PMID:
12451240
50.

Of mice and men: the road to tolerance.

Tolkoff-Rubin NE.

Curr Opin Nephrol Hypertens. 2002 Nov;11(6):579-81. Review. No abstract available.

PMID:
12394600

Supplemental Content

Loading ...
Support Center